Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | DCAF12L2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | SDK1 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |